CA-VERDEZYNE/WILL-&-CO
Verdezyne, Inc. , a privately-held industrial biotechnology company focused on producing renewable chemicals, has reached an agreement with Will & Co, a sales and marketing firm for raw materials, semi-finished products, additives, and pigments, for distribution of Verdezyne’s first commercial product. The exclusive agreement is for sales and distribution of BIOLON™ DDDA (biobased dodecanedioic acid or “DC12”) in Europe, one of the world’s largest chemical markets. BIOLON™ DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia. The agreement secures off-take for over 25% of the expected plant capacity.
Verdezyne’s BIOLON™ DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make engineering polymer resins, automotive parts, toothbrush bristles, cosmetics, fragrances, and more.
“This agreement with Will & Co is an important milestone for us because it reflects the strong demand for renewable chemicals and the demonstrated high quality of our product,” said E. William Radany, Ph.D., President and CEO of Verdezyne. “With a focus on serving customers, Will & Co is the perfect partner for us and we are proud to be associated with them. Having forged this mutually beneficial distribution partnership for a significant portion of our production capacity, we are even more excited to start producing BIOLON™ DDDA as soon as possible.”
Verdezyne’s plant, expected to open in 2017, is anticipated to have the capacity to produce over 10,000 metric tons of diacids annually, including BIOLON™ DDDA, drawing on Malaysia’s diverse and abundant base of plant-derived feedstocks.
“For some time, our customers have been asking us for an alternative to petroleum-derived chemicals, and Verdezyne’s BIOLON™ DDDA fits the bill perfectly,” commented Jacques van Lindonk, Managing Director at Will & Co. “We are excited to finally be able to offer them a biobased, versatile, sustainable chemical for such a wide variety of uses, at competitive prices. It is Will & Co’s focus to expand the product portfolio with biobased products, and through our cooperation with Verdezyne we take an important step forward.”
For samples, orders or more information about Verdezyne’s BIOLON ™ DDDA, please contact:
- Europe: ddda@will-co.nl
- Worldwide: ddda@verdezyne.com
About Verdezyne
Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of biobased chemicals. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. For more information, visit www.verdezyne.com or connect with the company on Twitter , LinkedIn or Facebook .
About Will & Co
Will & Co, established in the Netherlands in 1924, have been active in the distribution and trading of chemical raw materials ever since. During the years Will & Co has grown into an international supplier of specialty chemicals, high quality raw materials, additives and colorants. We cooperate very closely with the manufacturers of these products, mainly on the basis of exclusivity. Our experienced staff does everything to supply maximal service to our customers and business relations in the various industries. We offer a wide range of products, combined with the necessary know-how and support for production and product development. More information is available at www.will-co.nl .
View source version on businesswire.com: http://www.businesswire.com/news/home/20150609005567/en/
Contact:
Verdezyne, Inc.
Aida Yodites, 760-707-5200
Corporate
Communications
ayodites@verdezyne.com
or
Sparkpr
Bill
Douglass, 646-504-0890
bdouglass@sparkpr.com
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
The Coca-Cola Company Names New Leader for Europe Operating Unit18.7.2025 21:00:00 CEST | Press release
The Coca-Cola Company today announced that Luisa Ortega will become president of the Europe operating unit effective Sept. 1, succeeding Nikos Koumettis, who will retire in 2026 after a 25-year career with the company. Koumettis will remain with the company through Feb. 28, 2026, as a senior advisor. He will also serve on the board of directors of Hindustan Coca-Cola Beverages Pvt. Ltd., a company-owned bottler in India. Ortega joined Coca-Cola in 2019 and currently serves as president of the Africa operating unit. In this role, she leads a complex business that operates across 54 markets. Koumettis has led the Europe operating unit since it was created in 2021. “Luisa has done an outstanding job leading our African business, where our system has continued to make major investments to serve growing markets on the continent,” said Henrique Braun, Executive Vice President and Chief Operating Officer of The Coca-Cola Company. “As head of Europe, she will bring great international experien
NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador18.7.2025 15:00:00 CEST | Press release
Henry to utilize Amazfit products to optimize health, recovery and performance as he enters his 10th NFL season Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), announced Baltimore Ravens running back Derrick Henry as the newest elite athlete to join its growing roster of ambassadors. Known for his rare combination of speed and strength, Henry will utilize Amazfit wearables to power every phase of his training, recovery and sleep as he prepares for his 10th NFL season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250718322498/en/ Derrick Henry is the newest elite athlete to join Amazfit's growing roster of ambassadors. As one of the most prolific running backs of his generation, Henry has amassed an impressive array of accolades during his career, including NFL Offensive Player of the Year, two rushing titles, and five Pro Bowl selections. With Amazfit as his official smart wearable partne
Qualcomm Announces Quarterly Cash Dividend18.7.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on September 25, 2025, to stockholders of record at the close of business on September 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensin
MultiBank Group Confirms $MBG Token Listings on MEXC and Gate.io on TGE Day in Addition to MultiBank.io and Uniswap18.7.2025 14:34:00 CEST | Press release
MultiBank Group, the world’s largest & most regulated financial derivatives institution, is proud to announce that its highly anticipated $MBG Token will be listed on two new major global cryptocurrency exchanges — MEXC and Gate.io — on the day of its official Token Generation Event (TGE), July 22, 2025, in addition to MultiBank.io and Uniswap. The $MBG Token will go live on: MultiBank.ioGate.ioMEXCUniswap This new dual listing will allow millions of users across both exchanges to seamlessly access and trade $MBG using their existing accounts, ensuring immediate market participation at launch. The Token Generation Event (TGE) is now approaching following the successful completion of two pre-sale rounds, where MultiBank Group issued 7 million tokens in Round 1 and 3 million tokens in Round 2 — both of which sold out within minutes. Naser Taher, Chairman and Founder of MultiBank Group said “With $MBG, we’re introducing a utility token built to deliver real-world value, transparency, and
SLB Announces Second-Quarter 2025 Results18.7.2025 12:50:00 CEST | Press release
Revenue of $8.55 billion increased 1% sequentially and decreased 6% year on year GAAP EPS of $0.74 increased 28% sequentially and decreased 4% year on year EPS, excluding charges and credits, of $0.74 increased 3% sequentially and decreased 13% year on year Net income attributable to SLB of $1.01 billion increased 27% sequentially and decreased 9% year on year Adjusted EBITDA of $2.05 billion increased 2% sequentially and decreased 10% year on year Cash flow from operations was $1.14 billion and free cash flow was $622 million Board approved quarterly cash dividend of $0.285 per share SLB (NYSE: SLB) today announced results for the second-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716727689/en/ The exterior of the SLB headquarters in Houston, Texas. Second-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2025Mar. 31, 2025Jun. 30, 2024SequentialYear-on-yearReve
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum